Clinical Trial Update: Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on apremilast for active ulcerative colitis reports efficacy and safety findings. The study is completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2018-10-29